Skip to main content
Erschienen in: Forensic Toxicology 2/2019

03.06.2019 | Short Communication

A pilot study of non-targeted screening for stimulant misuse using high-resolution mass spectrometry

verfasst von: Patrícia Davies de Oliveira Sardela, Vinícius Figueiredo Sardela, Andressa Maia dos Santos da Silva, Henrique Marcelo Gualberto Pereira, Francisco Radler de Aquino Neto

Erschienen in: Forensic Toxicology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Forensic and anti-doping laboratories have used strategies based on targeted approaches in data processing, which means that only targeted compounds have been analyzed. The new challenges lie beyond the anticipation of molecular targets, such as the detection of designer drugs. In this research, after automatic extraction of all signals obtained by liquid chromatography–high-resolution mass spectrometry (LC–HRMS), the atypical pattern of stimulant-positive samples is evaluated to indicate potential doping substances by principal component analysis (PCA) when compared to negative samples.

Methods

The capacity for discrimination of positive samples by PCA was evaluated using 24 samples reported as an adverse analytical finding (AAF) for stimulants from different sports against their corresponding negative controls. The method was then evaluated on routine analysis of 620 samples.

Results

AAF samples for stimulants presented an atypical pattern positioning when compared to negative samples in the multidimensional space of PCA. The method was able to identify 22 samples reported as AAF before checking the targeted substance windows. In that scenario, it also allows the detection of designer stimulants when the present procedure is applied complementarily in screening routine analysis. The present approach was applied simultaneously with the targeted procedure through the evaluation of 620 samples without jeopardizing the results deadline.

Conclusions

Non-targeted analysis of stimulants by PCA as applied to athlete urine samples was demonstrated for the first time to be capable of flagging positive samples in sport competitions, showing its promise as a complementary screening tool alongside classical methods and as a straightforward approach for selecting samples for long-term storage.
Literatur
1.
Zurück zum Zitat Pereira HMG, Sardela VF, Padilha MC, Mirotti L, Casilli A, de Oliveira FA, de Albuquerque Cavalcanti G, Rodrigues LML, de Araujo ALD, Levy RS, Teixeira PAC, de Oliveira FAG, Duarte ACG, Carneiro ACD, Evaristo JAM, Dos Santos GRC, da Costa GCV, de Lima Castro F, Nogueira FCS, Scalco FB, Pizzatti L, de Aquino Neto FR (2017) Doping control analysis at the Rio 2016 Olympic and Paralympic games. Drug Test Anal 9:1658–1672CrossRefPubMed Pereira HMG, Sardela VF, Padilha MC, Mirotti L, Casilli A, de Oliveira FA, de Albuquerque Cavalcanti G, Rodrigues LML, de Araujo ALD, Levy RS, Teixeira PAC, de Oliveira FAG, Duarte ACG, Carneiro ACD, Evaristo JAM, Dos Santos GRC, da Costa GCV, de Lima Castro F, Nogueira FCS, Scalco FB, Pizzatti L, de Aquino Neto FR (2017) Doping control analysis at the Rio 2016 Olympic and Paralympic games. Drug Test Anal 9:1658–1672CrossRefPubMed
2.
Zurück zum Zitat Sobolevsky T, Krotov G, Dikunets M, Nikitina M, Mochalova E, Rodchenkov G (2014) Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014. Drug Test Anal 6:1087–1101CrossRefPubMed Sobolevsky T, Krotov G, Dikunets M, Nikitina M, Mochalova E, Rodchenkov G (2014) Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014. Drug Test Anal 6:1087–1101CrossRefPubMed
3.
Zurück zum Zitat de Aquino Neto FR, Sarderla VF, Mirotti L, Pizzatti L (2016) Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016. Bioanalysis 8:1753–1756CrossRefPubMed de Aquino Neto FR, Sarderla VF, Mirotti L, Pizzatti L (2016) Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016. Bioanalysis 8:1753–1756CrossRefPubMed
6.
Zurück zum Zitat Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R (2007) Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 8:1243–1266CrossRefPubMed Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R (2007) Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 8:1243–1266CrossRefPubMed
7.
Zurück zum Zitat Kaddurah-Daouk R, Weinshilboum R (2015) Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine. Clin Pharmacol Ther 98:71–75CrossRefPubMedPubMedCentral Kaddurah-Daouk R, Weinshilboum R (2015) Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine. Clin Pharmacol Ther 98:71–75CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Raro M, Ibáñez M, Gil R, Fabregat A, Tudela E, Deventer K, Ventura R, Segura J, Marcos J, Kotronoulas A, Joglar J, Farré M, Yang S, Xing Y, Van Eenoo P, Pitarch E, Hernández F, Sancho JV, Pozo ÓJ (2015) Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometry. Anal Chem 87:8373–8380CrossRefPubMed Raro M, Ibáñez M, Gil R, Fabregat A, Tudela E, Deventer K, Ventura R, Segura J, Marcos J, Kotronoulas A, Joglar J, Farré M, Yang S, Xing Y, Van Eenoo P, Pitarch E, Hernández F, Sancho JV, Pozo ÓJ (2015) Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometry. Anal Chem 87:8373–8380CrossRefPubMed
10.
Zurück zum Zitat Kiss A, Jacquet A-L, Paisse O, Flament-Waton M-M, de Ceaurriz J, Bordes C, Gauvrit J-Y, Lantéri P, Cren-Olivé C (2011) Urinary signature of anabolic steroids and glucocorticoids in humans by LC–MS. Talanta 83:1769–1773CrossRefPubMed Kiss A, Jacquet A-L, Paisse O, Flament-Waton M-M, de Ceaurriz J, Bordes C, Gauvrit J-Y, Lantéri P, Cren-Olivé C (2011) Urinary signature of anabolic steroids and glucocorticoids in humans by LC–MS. Talanta 83:1769–1773CrossRefPubMed
11.
Zurück zum Zitat Alladio E, Caruso R, Gerace E, Amante E, Salomone A, Vincenti M (2016) Application of multivariate statistics to the steroidal module of the athlete biological passport: a proof of concept study. Anal Chim Acta 922:19–29CrossRefPubMed Alladio E, Caruso R, Gerace E, Amante E, Salomone A, Vincenti M (2016) Application of multivariate statistics to the steroidal module of the athlete biological passport: a proof of concept study. Anal Chim Acta 922:19–29CrossRefPubMed
12.
Zurück zum Zitat Sardela VF, Martucci MEP, de Araújo ALD, Leal EC, Oliveira DS, Carneiro GRA, Deventer K, Van Eenoo P, Pereira HMG, Aquino Neto FR (2018) Comprehensive analysis by liquid chromatography Q-Orbitrap mass spectrometry: fast screening of peptides and organic molecules. J Mass Spectrom 53:476–503CrossRefPubMed Sardela VF, Martucci MEP, de Araújo ALD, Leal EC, Oliveira DS, Carneiro GRA, Deventer K, Van Eenoo P, Pereira HMG, Aquino Neto FR (2018) Comprehensive analysis by liquid chromatography Q-Orbitrap mass spectrometry: fast screening of peptides and organic molecules. J Mass Spectrom 53:476–503CrossRefPubMed
13.
Zurück zum Zitat Cawley A, Pasin D, Ganbat N, Ennis L, Smart C, Greer C, Keledjian J, Fu S, Chen A (2016) The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometry. Anal Methods 8:1789–1797CrossRef Cawley A, Pasin D, Ganbat N, Ennis L, Smart C, Greer C, Keledjian J, Fu S, Chen A (2016) The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometry. Anal Methods 8:1789–1797CrossRef
14.
Zurück zum Zitat Saugy M, Robinson N, Saudan C (2009) The fight against doping: back on track with blood. Drug Test Anal 1:474–478CrossRefPubMed Saugy M, Robinson N, Saudan C (2009) The fight against doping: back on track with blood. Drug Test Anal 1:474–478CrossRefPubMed
15.
Zurück zum Zitat Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5:142–149CrossRefPubMed Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5:142–149CrossRefPubMed
16.
Zurück zum Zitat Zhang S, Liu L, Steffen D, Ye T, Raftery D (2012) Metabolic profiling of gender: headspace-SPME/GC–MS and 1H NMR analysis of urine. Metabolomics 8:323–334CrossRef Zhang S, Liu L, Steffen D, Ye T, Raftery D (2012) Metabolic profiling of gender: headspace-SPME/GC–MS and 1H NMR analysis of urine. Metabolomics 8:323–334CrossRef
17.
Zurück zum Zitat Yan B, A J, Wang G, Lu H, Huang X, Liu Y, Zha W, Hao H, Zhang Y, Liu L, Gu S, Huang Q, Zheng Y, Sun J (2009) Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training. J Appl Physiol 106:531–538CrossRefPubMed Yan B, A J, Wang G, Lu H, Huang X, Liu Y, Zha W, Hao H, Zhang Y, Liu L, Gu S, Huang Q, Zheng Y, Sun J (2009) Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training. J Appl Physiol 106:531–538CrossRefPubMed
19.
Zurück zum Zitat Janssen PAJ, Leysen JE, Megens AAHP, Awouters FHL (1999) Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol 2:229–240CrossRefPubMed Janssen PAJ, Leysen JE, Megens AAHP, Awouters FHL (1999) Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol 2:229–240CrossRefPubMed
20.
Zurück zum Zitat Cone EJ, Tsadik A, Oyler J, Darwin WD (1998) Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit 20:556–560 Cone EJ, Tsadik A, Oyler J, Darwin WD (1998) Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit 20:556–560
23.
Zurück zum Zitat Pereira HMG, Sardela VF (2014) Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges. Subst Use Misuse 49:1098–1114CrossRefPubMed Pereira HMG, Sardela VF (2014) Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges. Subst Use Misuse 49:1098–1114CrossRefPubMed
24.
Zurück zum Zitat Perrenoud L, Saugy M, Saudan C (2009) Detection in urine of 4-methyl-2-hexaneamine, a doping agent. J Chromatogr B 877:3767–3770CrossRef Perrenoud L, Saugy M, Saudan C (2009) Detection in urine of 4-methyl-2-hexaneamine, a doping agent. J Chromatogr B 877:3767–3770CrossRef
25.
Zurück zum Zitat Deventer K, Roels K, Delbeke FT, Van Eenoo P (2011) Prevalence of legal and illegal stimulating agents in sports. Anal Bioanal Chem 401:421–432CrossRefPubMed Deventer K, Roels K, Delbeke FT, Van Eenoo P (2011) Prevalence of legal and illegal stimulating agents in sports. Anal Bioanal Chem 401:421–432CrossRefPubMed
Metadaten
Titel
A pilot study of non-targeted screening for stimulant misuse using high-resolution mass spectrometry
verfasst von
Patrícia Davies de Oliveira Sardela
Vinícius Figueiredo Sardela
Andressa Maia dos Santos da Silva
Henrique Marcelo Gualberto Pereira
Francisco Radler de Aquino Neto
Publikationsdatum
03.06.2019
Verlag
Springer Singapore
Erschienen in
Forensic Toxicology / Ausgabe 2/2019
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-019-00482-1

Weitere Artikel der Ausgabe 2/2019

Forensic Toxicology 2/2019 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …